Rhiannon Morris, Senior Research Officer at WEHI (Walter and Eliza Hall Institute of Medical Research), shared a post on LinkedIn:
“Thrilled to share that I have been awarded an Early Career Cancer Research Fellowship Victoria Grant to support my research for the next 3 years.
My project titled ‘Novel immunotherapeutic approaches to prevent TP53 mutated acute myeloid leukemia’ will use cutting edge proteomics techniques on patient AML samples to identify new targets for this devastating disease.
Thank you to Cancer Council Victoria and The Victorian Department of Health for supporting my work. This work will be undertaken at WEHI (Walter and Eliza Hall Institute of Medical Research).”
More posts on OncoDaily.